SSG
AKAO

Summit Securities Group’s Achaogen Inc AKAO Stock Holding History

Summit Securities Group’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-100
Closed -$1K – 789
2014
Q3 		$1K Buy
+100
New +$1.02K ﹤0.01% 669

Other funds holding AKAO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Summit Securities Group's AKAO Position: Q4 2014 in Review

Summit Securities Group sold out of Achaogen Inc (AKAO) in Q4 2014, closing a stake of 100 shares — an estimated $1K sold.

Summit Securities Group first reported a position in AKAO in Q3 2014 and held it in 1 quarter. The position peaked at $1K in Q3 2014. 51 funds tracked by Wall St. Rank hold AKAO as of Q4 2014.

  • Summit Securities Group reported no remaining Achaogen Inc position as of Q4 2014 after selling out during the quarter.
  • Summit Securities Group sold 100 Achaogen Inc shares in Q4 2014, an estimated $1K.
  • Summit Securities Group first reported a position in Achaogen Inc in Q3 2014 and held it in 1 quarter.
  • Summit Securities Group's Achaogen Inc position peaked at $1K in Q3 2014.
  • 51 funds tracked by Wall St. Rank held Achaogen Inc as of Q4 2014.

Based on Summit Securities Group's 13F filing for Q4 2014, filed 5 Feb 2015.